Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-25
2005-10-25
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S281000
Reexamination Certificate
active
06958341
ABSTRACT:
The present invention relates to pyrazolopyrimidines according to formula (I)and stereoisomers, isomers and salts thereof wherein R1-R5are selected from certain alkyl, aryl and heteroaryl species as defined in the specification wherein all of the compounds are useful as CRF antagonists and are thus useful in the treatment of neurological disorders as well as a multitude of other CRF associated diseases or conditions.
REFERENCES:
patent: 3910907 (1975-10-01), O'Brien et al.
patent: 3920652 (1975-11-01), Springer et al.
patent: 3995039 (1976-11-01), Rooney et al.
patent: 4021556 (1977-05-01), Springer et al.
patent: 4567263 (1986-01-01), Eicken et al.
patent: 4621556 (1986-11-01), Soltysiak et al.
patent: 4892576 (1990-01-01), Kruger et al.
patent: 4997940 (1991-03-01), Vinogradoff et al.
patent: 5137887 (1992-08-01), Hashimoto et al.
patent: 5397774 (1995-03-01), Nugent et al.
patent: 5484760 (1996-01-01), Bussler et al.
patent: 4243279 (1994-06-01), None
patent: 0025819 (1981-04-01), None
patent: 0129847 (1985-01-01), None
patent: 0374448 (1990-06-01), None
patent: 0531901 (1993-03-01), None
patent: 0511528 (1994-02-01), None
patent: 0549149 (1994-04-01), None
patent: 0662477 (1995-07-01), None
patent: 0269859 (1995-10-01), None
patent: 0714898 (1996-06-01), None
patent: 0521622 (1997-08-01), None
patent: 0591528 (1998-12-01), None
patent: 9510506 (1995-04-01), None
patent: 9535298 (1995-12-01), None
patent: 9729109 (1997-08-01), None
patent: 9803510 (1998-01-01), None
patent: 9808847 (1998-03-01), None
patent: 9901454 (1999-01-01), None
Suzuki, M.; Iwasaki, H.; Fujikawa, Y.; Sakashita, M.; Kitahara, M.; Sakoda, R., Bioorganic & Medicinal Chemistry Letters, 11(10), 1285-1288, 2001.
McCarthy, J.R. et al, Ann. Reports Med. Chem., vol. 34, 1999, 11-20.
Springer et al, J. Med. Chem., 1976, vol. 19, No. 2, 291-296.
Joshi et al., J. Prakt. Chemie, 321, 2, 1979, 341-344.
Maquestiau et al., Bull. Soc. Belg., vol. 101, No. 2, 1992, pp. 131-136.
Ibrahim et al., Arch. Pharm. (weinheim) 320, 487-491 (1987).
J. Med. Chem. 24, 610-613 (1981).
J. Het. Chem., 22, 601 (1985).
Gilligan Paul J.
Wilde Richard G.
Bristol-Myers Squibb Pharma Company
Makujina Shad R.
McKenzie Thomas C.
Woodcock & Washburn LLP
LandOfFree
Pyrazolopyrimidines as CRF antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolopyrimidines as CRF antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolopyrimidines as CRF antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3436446